Core Scientific, Inc. (CORZQ) Stock News: Robbins LLP is Investigating the Officers and Directors of Core Scientific, Inc. on Behalf of Investors

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP is investigating Core Scientific, Inc. (OTC: CORZQ) to determine whether certain Core Scientific officers and directors violated securities laws and breached fiduciary duties to shareholders by engaging in a conflicted SPAC process. In January 2022, special purpose acquisition company Power and Digital Infrastructure Acquisition Corp. completed a business combination with Core Scientific Holding Co. The combined company began trading as Core Scientific, Inc. on January 19, 2022. In November 2022, the Company disclosed the discovery of material weaknesses in its internal control over financial reporting. The Company filed for bankruptcy on December 21, 2022.

What Now: Core Scientific, Inc. shareholders have legal options. If you owned shares of Power and Digital Infrastructure Acquisition Corp. at the time of the business combination and have incurred significant loss in the stock, contact us for more information about your rights.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Contact us to learn more:

Aaron Dumas, Jr.
[phone]
[e-mail]
Shareholder Information Form

About Robbins LLP: Some law firms issuing releases about this matter do not actually litigate securities class actions; Robbins LLP does. A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. Since our inception, we have obtained over $1 billion for shareholders.

To be notified if a class action against Core Scientific, Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.